Sign inJoin waitlistJoin the waitlist

Filippo Milano

Director, Cord Blood Transplant Program, Fred Hutch · University of Washington School of Medicine

Credentials: · · ·

History

University of Washington School of Medicine
Present
University of Washington School of Medicine
Present
University of Washington School of Medicine
Present

Hematology and Medical Oncology
University of Washington-Seattle Campus
2017–2020
University La Sapienza Rome
2014–2017
Doctor of Medicine
1997–2001

Research

Cord-Blood Transplantation in Patients with Minimal Residual Disease
New England Journal of Medicine · 2016 · First of 16 authors · 380 citations
Impact of pretransplantation minimal residual disease, as detected by multiparametric flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute…
Journal of Clinical Oncology · 2011 · 342 citations
Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignancies
Blood · 2021 · 166 citations

Colleen Delaney
36 papers · 3 as a resident
Brenda Sandmaier
19 papers
Ann Dahlberg
15 papers
Frederick Appelbaum
15 papers
Roland Walter
15 papers
Michael Boeckh
13 papers
Aude Chapuis
12 papers
Mazyar Shadman
11 papers
Joshua Hill
10 papers
Rachel Salit
10 papers
Brian Till
9 papers
CT
Cameron Turtle
9 papers

Grants

CCR5 Analyses in HIV Infected Hematology Patients Undergoing Umbilical Cord Blood Allogeneic Transplantation
National Heart, Lung, and Blood Institute · R34
Contact PI · $836.8K · Fred Hutchinson Cancer Center
2018–2024

Clinical trials

Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer
Principal investigator · Recruiting · Phase 2
Fred Hutchinson Cancer Center
2025–2029
Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers
Principal investigator · Terminated · Phase 2
Fred Hutchinson Cancer Center
2022
Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes
Principal investigator · Active not recruiting · Phase 2
Fred Hutchinson Cancer Center
2022–2027
CPX-351 Versus Immediate Stem Cell Transplantation for the Treatment of High-Grade Myeloid Cancers With Measurable Residual Disease
Principal investigator · Terminated · Phase 2
Fred Hutchinson Cancer Center
2021–2023